• No results found

Cost-effectiveness of Evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular disease

N/A
N/A
Protected

Academic year: 2019

Share "Cost-effectiveness of Evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular disease"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1. Baseline Characteristics of the Atherosclerotic Cardiovascular Disease Patient Populationin the FOURIER Trial and US Population From NHANES
Table 2. Key Inputs in the Model
Table 3. Total Costs, QALY, and ICER
Table 4. Sensitivity and Scenario Analyses
+2

References

Related documents

Further testing was done using ethanol, as that was the solvent to be used in the reaction. While ethanol has a boiling point o f 78.4 °C at

Significantly higher proportions of participants receiving delamanid experienced QT prolonga- tion, and the frequency appeared to be dose dependent (9.9% for delamanid 100 mg

For more exploration of the relationship between the managers’ behavior and personality aspects (overconfidence, optimism and risk aversion) and the firms’ leverage

Exchange rates and bond yields have more influence in emerging markets than in developing countries.. My findings have

Fuzzy Neuro Technology is being employed on business applications to provide the quality services to

K, Fault-Tolerant Voltage Source Inverter for Permanent Magnet synchronous motor, International Journal of Advanced Research in Electrical, Electronics and

1) We motivate strong isolation of replacement metadata by demonstrating that the replacement policy can leak information (cf. Section II-B2) in a way-partitioned cache. 2) We design

At the end of a rare canoe trip, his little brother Woody had said that he felt like he was the water and the v/ater was him.. One of Woody's